Novocure Ltd (NVCR) Stock Ticker
NVCR right now
Market factors today
Unlock the full NVCR picture
About Novocure Ltd
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
NVCR stock facts
| Ticker symbol | NVCR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $1.8B |
| CEO | Frank Leonard |
| Employees | 1,605 |
| Headquarters | Baar, CH |
| IPO date | 2015-10-02 |
| Website | www.novocure.com |
What you can see for NVCR on Tickr
Live NVCR price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the NVCR report.
Rankings
FAQ
What is the ticker symbol for Novocure Ltd?
The ticker symbol for Novocure Ltd is NVCR, listed on the NASDAQ.
What is NVCR?
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating…